ALEC
ALEC
NASDAQ · Biotechnology

Alector Inc

$2.16
-0.14 (-6.09%)
As of May 16, 2:05 AM ET ·
Financial Highlights (FY 2026)
Revenue
22.68M
Net Income
-154,069,643
Gross Margin
Profit Margin
-679.2%
Rev Growth
-46.0%
D/E Ratio
0.32
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 64.5% 64.5%
Operating Margin -741.3% -667.2% 8.6% 8.1%
Profit Margin -679.2% -645.2% 9.4% 7.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 22.68M 42.00M 87.33M 87.17M
Gross Profit 56.35M 56.25M
Operating Income -168,144,957 -280,189,708 7.53M 7.07M
Net Income -154,069,643 -256,735,194 8.20M 6.12M
Gross Margin 64.5% 64.5%
Operating Margin -741.3% -667.2% 8.6% 8.1%
Profit Margin -679.2% -645.2% 9.4% 7.0%
Rev Growth -46.0% -46.0% +6.5% -4.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 28.80M 28.80M 37.32M 37.66M
Total Equity 91.11M 91.11M 74.11M 65.78M
D/E Ratio 0.32 0.32 0.50 0.57
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -147,719,002 -259,827,905 10.19M 12.10M
Free Cash Flow 6.96M 5.08M